WILMINGTON — Christopher Cano has been picked as the new Chief Executive Officer of Cellergy Pharma Inc., a preclinical biotechnology firm developing novel therapies for severe allergic diseases.The appointment marks a strategic shift as the Delaware-based company prepares to accelerate the development of its flagship CAR T-cell therapy. “I am honored to begin leading Cellergy Pharma at this exciting, pivotal …
A Delaware Division of Small Business program that gives small business grants to start or grow has awarded cash to 100 businesses in its first five years. The EDGE competition — short for Encouraging Development, Growth and Expansion competition — reached that milestone Thursday, when it gave money to 10 small businesses in the first of its biannual awards. In …
CorriXR Therapeutics was given the “Most Promising New Company” award by attendees at the inaugural Delaware’s DNA 2023 Life Science Conference. Sponsored by Delaware Bio, the conference attracted 300 people to network and hear panels about industry trends. CorriXR, the first spin-out of ChristianaCare’s Gene Editing Institute, is an oncology-focused biotherapeutics development company with what they describe as a ground-breaking …
